[A six-day subrenal capsule assay for predictive testing of primary human tumors]. 1988

E Yokoyama, and N Irimajiri, and M Shirakabe, and M Matsumoto, and J Haneda, and T Kusunoki, and J Utsunomiya
2nd Dept. of Surgery, Hyogo College of Medicine.

We carried out a total of 36 in vivo chemosensitivity tests in 33 cases of human malignant tumor using the subrenal capsule assay, developed by A.E. Bogden et al. Of the 36 assays, 31 were evaluable. The chemosensitivity of each tumor varied individually. UFT, 5-fluorouracil, mitomycin-C and adriamycin were administered to gastrointestinal cancer patients regularly, but our SRC-assay showed a high sensitivity rate for UFT and 5-fluorouracil but a low sensitivity rate for mitomycin-C and adriamycin. Nine patients had clinically evaluable lesions and a correlation between the assay results and clinical response existed in 6 cases. The true positive rate was 50% (3/6), the true negative rate 100% (3/3), and the overall predictive accuracy 66% (6/9). This study suggested that 6-day SRC assay is useful for selecting effective anti-tumor agents for the treatment of cancer patients.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D013370 Subrenal Capsule Assay In vivo method of screening investigative anticancer drugs and biologic response modifiers for individual cancer patients. Fresh tumor tissue is implanted under the kidney capsule of immunocompetent mice or rats; gross and histological assessments follow several days after tumor treatment in situ. Subrenal Capsule Xenograft Assay,Assay, Subrenal Capsule,Assays, Subrenal Capsule,Subrenal Capsule Assays
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

E Yokoyama, and N Irimajiri, and M Shirakabe, and M Matsumoto, and J Haneda, and T Kusunoki, and J Utsunomiya
April 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
E Yokoyama, and N Irimajiri, and M Shirakabe, and M Matsumoto, and J Haneda, and T Kusunoki, and J Utsunomiya
March 1984, Cancer treatment reviews,
E Yokoyama, and N Irimajiri, and M Shirakabe, and M Matsumoto, and J Haneda, and T Kusunoki, and J Utsunomiya
June 1984, Cancer research,
E Yokoyama, and N Irimajiri, and M Shirakabe, and M Matsumoto, and J Haneda, and T Kusunoki, and J Utsunomiya
October 1989, The Journal of urology,
E Yokoyama, and N Irimajiri, and M Shirakabe, and M Matsumoto, and J Haneda, and T Kusunoki, and J Utsunomiya
January 1988, Zentralblatt fur Gynakologie,
E Yokoyama, and N Irimajiri, and M Shirakabe, and M Matsumoto, and J Haneda, and T Kusunoki, and J Utsunomiya
January 1988, Journal of medicine,
E Yokoyama, and N Irimajiri, and M Shirakabe, and M Matsumoto, and J Haneda, and T Kusunoki, and J Utsunomiya
April 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
E Yokoyama, and N Irimajiri, and M Shirakabe, and M Matsumoto, and J Haneda, and T Kusunoki, and J Utsunomiya
January 1988, Progress in clinical and biological research,
E Yokoyama, and N Irimajiri, and M Shirakabe, and M Matsumoto, and J Haneda, and T Kusunoki, and J Utsunomiya
July 1981, Cancer,
E Yokoyama, and N Irimajiri, and M Shirakabe, and M Matsumoto, and J Haneda, and T Kusunoki, and J Utsunomiya
February 1984, Gynecologic oncology,
Copied contents to your clipboard!